| Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ... The Lancet 396 (10266), 1885-1894, 2020 | 330 | 2020 |
| COVID-19 outcomes in patients with hematologic disease F Malard, A Genthon, E Brissot, Z van de Wyngaert, Z Marjanovic, S Ikhlef, ... Bone marrow transplantation 55 (11), 2180-2184, 2020 | 197 | 2020 |
| Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome–positive acute … S Giebel, A Czyz, O Ottmann, F Baron, E Brissot, F Ciceri, JJ Cornelissen, ... Cancer 122 (19), 2941-2951, 2016 | 185 | 2016 |
| Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute … E Brissot, M Labopin, MM Beckers, G Socié, A Rambaldi, L Volin, J Finke, ... haematologica 100 (3), 392, 2015 | 179 | 2015 |
| Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients A Spyridonidis, M Labopin, BN Savani, R Niittyvuopio, D Blaise, ... Bone marrow transplantation 55 (6), 1114-1125, 2020 | 145 | 2020 |
| Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from … A Bazarbachi, G Bug, F Baron, E Brissot, F Ciceri, I Abou Dalle, H Döhner, ... haematologica 105 (6), 1507, 2020 | 138 | 2020 |
| Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies F Malard, B Gaugler, J Gozlan, L Bouquet, D Fofana, L Siblany, D Eshagh, ... Blood cancer journal 11 (8), 142, 2021 | 130 | 2021 |
| Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria G Battipaglia, F Malard, MT Rubio, A Ruggeri, AC Mamez, E Brissot, ... Haematologica 104 (8), 1682, 2019 | 123 | 2019 |
| Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms‐like tyrosine kinase 3‐mutated acute myeloid leukemia G Battipaglia, A Ruggeri, R Massoud, J El Cheikh, M Jestin, A Antar, ... Cancer 123 (15), 2867-2874, 2017 | 118 | 2017 |
| Early cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplantation R Duléry, R Mohty, M Labopin, S Sestili, F Malard, E Brissot, G Battipaglia, ... Cardio Oncology 3 (2), 250-259, 2021 | 104 | 2021 |
| Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients A Ruggeri, G Roth‐Guepin, G Battipaglia, AC Mamez, F Malard, A Gomez, ... Transplant Infectious Disease 17 (6), 822-830, 2015 | 98 | 2015 |
| Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working … E Brissot, M Labopin, G Ehninger, M Stelljes, A Brecht, A Ganser, ... Haematologica 104 (3), 524, 2018 | 97 | 2018 |
| Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation F Malard, RM Szydlo, E Brissot, P Chevallier, T Guillaume, J Delaunay, ... Biology of blood and marrow transplantation 16 (1), 28-34, 2010 | 96 | 2010 |
| Pathophysiology and classification of iron overload diseases; update 2018 P Brissot, MB Troadec, O Loréal, E Brissot Transfusion Clinique et Biologique 26 (1), 80-88, 2019 | 90 | 2019 |
| UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a … R Benjamin, N Jain, MV Maus, N Boissel, C Graham, A Jozwik, D Yallop, ... The Lancet Haematology 9 (11), e833-e843, 2022 | 86 | 2022 |
| Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation Z Peric, X Cahu, P Chevallier, E Brissot, F Malard, T Guillaume, ... Leukemia 25 (6), 932-938, 2011 | 85 | 2011 |
| Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute … A Nagler, M Labopin, M Houhou, M Aljurf, A Mousavi, RM Hamladji, ... Journal of Hematology & Oncology 14, 1-12, 2021 | 83 | 2021 |
| Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous … A de Masson, M Beylot-Barry, JD Bouaziz, RP de Latour, F Aubin, ... haematologica 99 (3), 527, 2014 | 83 | 2014 |
| Sequential conditioning with thiotepa in T cell-replete hematopoietic stem cell transplantation for the treatment of refractory hematologic malignancies: comparison with … R Duléry, AL Ménard, S Chantepie, J El-Cheikh, S François, J Delage, ... Biology of Blood and Marrow Transplantation 24 (5), 1013-1021, 2018 | 80 | 2018 |
| Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival F Malard, M Labopin, P Chevallier, T Guillaume, A Duquesne, F Rialland, ... Blood, The Journal of the American Society of Hematology 127 (14), 1828-1835, 2016 | 75 | 2016 |
